Henry Schein, Inc. $HSIC Shares Sold by Deutsche Bank AG

Deutsche Bank AG decreased its position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 41.0% during the first quarter, according to its most recent filing with the SEC. The firm owned 381,816 shares of the company's stock after selling 265,206 shares during the period. Deutsche Bank AG owned about 0.31% of Henry Schein worth $26,151,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in HSIC. Investment Management Corp VA ADV bought a new stake in shares of Henry Schein in the 4th quarter worth approximately $32,000. Rakuten Securities Inc. purchased a new stake in Henry Schein during the 1st quarter valued at $34,000. Whittier Trust Co. raised its stake in Henry Schein by 714.3% during the 1st quarter. Whittier Trust Co. now owns 798 shares of the company's stock valued at $55,000 after buying an additional 700 shares during the last quarter. UMB Bank n.a. raised its stake in Henry Schein by 23.2% during the 1st quarter. UMB Bank n.a. now owns 1,066 shares of the company's stock valued at $73,000 after buying an additional 201 shares during the last quarter. Finally, Allworth Financial LP increased its stake in shares of Henry Schein by 24.5% in the 1st quarter. Allworth Financial LP now owns 1,178 shares of the company's stock worth $78,000 after purchasing an additional 232 shares in the last quarter. Hedge funds and other institutional investors own 96.62% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on HSIC shares. Robert W. Baird restated a "neutral" rating and issued a $72.00 price objective (down from $82.00) on shares of Henry Schein in a research note on Monday, July 14th. UBS Group dropped their price objective on shares of Henry Schein from $75.00 to $70.00 and set a "neutral" rating for the company in a report on Wednesday, August 6th. Stifel Nicolaus reaffirmed a "hold" rating and issued a $75.00 price target (down previously from $80.00) on shares of Henry Schein in a report on Friday, July 25th. Piper Sandler decreased their price objective on shares of Henry Schein from $83.00 to $77.00 and set an "overweight" rating for the company in a research note on Wednesday, April 30th. Finally, Leerink Partners set a $75.00 price objective on shares of Henry Schein in a research note on Monday, July 14th. Nine research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat, Henry Schein has a consensus rating of "Hold" and an average price target of $75.58.

Henry Schein Stock Down 0.2%

HSIC traded down $0.14 during trading on Monday, hitting $67.70. The stock had a trading volume of 357,762 shares, compared to its average volume of 1,767,340. The company has a market capitalization of $8.21 billion, a PE ratio of 21.83, a PEG ratio of 2.24 and a beta of 0.81. Henry Schein, Inc. has a twelve month low of $60.56 and a twelve month high of $82.49. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.78 and a current ratio of 1.41. The stock has a 50 day simple moving average of $70.81 and a two-hundred day simple moving average of $70.72.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its earnings results on Tuesday, August 5th. The company reported $1.10 earnings per share for the quarter, missing the consensus estimate of $1.19 by ($0.09). The firm had revenue of $3.24 billion during the quarter, compared to analyst estimates of $3.22 billion. Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. Henry Schein's revenue was up 3.3% on a year-over-year basis. During the same quarter last year, the business earned $1.23 earnings per share. On average, research analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.